- Medicure Inc. (TSXV:MPH, OTC:MCUJF) to present 2024 year-end financial results on April 29, 2025.
- Investors can join the conference call at 8:30 AM ET, following the filing of results after market close on April 28, 2025.
- A webcast of the conference call will be available, with a recording posted on the company's website.
Medicure Inc. (TSXV:MPH, OTC:MCUJF), a pharmaceutical company focused on the U.S. market, will announce its 2024 year-end financial results via a conference call scheduled for April 29, 2025, at 8:30 AM Eastern Time. The financial results will be filed after the market closes on April 28, 2025, providing investors the opportunity to analyze the company's performance over the past year.
The conference call will include a question-and-answer session, allowing participants to engage with Medicure's management about the published financial results and the company's operations. Investors interested in joining the call can use the toll-free number 1-877-545-0320, or the international number 1-973-528-0002 with the participant access code 636803. Additionally, a live webcast of the call will be available at webcaster4.com.
Medicure specializes in the marketing and distribution of AGGRASTAT® (tirofiban hydrochloride) injection and ZYPITAMAG® (pitavastatin) tablets in the United States through its subsidiary Medicure Pharma Inc. The company also operates Marley Drug, Inc., which serves all 50 states, Washington D.C., and Puerto Rico, focusing on improving medication access coupled with excellent customer service.
